CaTe
Hongo
About CaTe
CaTe is based in Tokyo. CaTe develops and manufactures a Digital Therapeutic (DTx) for remote cardiac rehabilitation. Their invention allows heart disease patients to safely and successfully complete cardiac rehabilitation utilizing standing exercise in a confined space, such as at home, without the use of ergometers or similar instruments.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Total funding: $15.3M
- Funding stage: Early Stage Venture
- Last round: Series B (Aug 2025)
- Website: cate.co.jp
- Phone: +81 036-273-8578
Industries & Categories
Information Technology, Manufacturing, Medical Device, Sales
Canonical: https://fsome.com/organization/cate-87222 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.